These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23711358)

  • 21. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
    Socolov D; Blidaru I; Tamba B; Miron N; Boiculese L; Socolov R
    Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):480-7. PubMed ID: 21942657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of the levonorgestrel-releasing intrauterine system in perimenopausal women with menorrhagia or dysmenorrhea.
    Yoo HJ; Lee MA; Ko YB; Yang JB; Kang BH; Lee KH
    Arch Gynecol Obstet; 2012 Jan; 285(1):161-6. PubMed ID: 21671063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya.
    Hubacher D; Masaba R; Manduku CK; Chen M; Veena V
    Contraception; 2015 Apr; 91(4):295-300. PubMed ID: 25601351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies.
    Jensen J; Mansour D; Lukkari-Lax E; Inki P; Burock K; Fraser IS
    Contraception; 2013 Jan; 87(1):107-12. PubMed ID: 23040140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
    Borgatta L; Buhling KJ; Rybowski S; Roth K; Rosen K
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):372-9. PubMed ID: 27494570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U; Ebru A; Murat E; Levent Y
    Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J; Aldrighi JM; de Lima GR
    Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study.
    Khalighi M; Wheeler AP; Adeyemi-Fowode OA; Kouides PA; Durazo-Arvizu RA; Haley K; Dersch CM; Weyand AC; Baldwin MK; Borzutzky C
    J Adolesc Health; 2022 Aug; 71(2):204-209. PubMed ID: 35430143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS; Reardon B; Arepally G
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis.
    Oliveira JA; Eskandar K; Chagas J; do Nascimento LLO; Ribeiro DD; Rocha ALL; de Oliveira FR
    Contraception; 2024 Jul; 135():110450. PubMed ID: 38614274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of the levonorgestrel intrauterine system in obese women with heavy menstrual bleeding.
    Shaw V; Vandal AC; Coomarasamy C; Ekeroma AJ
    Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):619-623. PubMed ID: 27696346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experiences of Gender Minority Youth With the Intrauterine System.
    Akgul S; Bonny AE; Ford N; Holland-Hall C; Chelvakumar G
    J Adolesc Health; 2019 Jul; 65(1):32-38. PubMed ID: 30691940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC; Virtanen-Kari S
    BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil).
    Pisoni CN; Cuadrado MJ; Khamashta MA; Hunt BJ
    Lupus; 2006; 15(12):877-80. PubMed ID: 17211994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
    Endrikat J; Shapiro H; Lukkari-Lax E; Kunz M; Schmidt W; Fortier M
    J Obstet Gynaecol Can; 2009 Apr; 31(4):340-347. PubMed ID: 19497153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception.
    Furlani RM; Garcia E; Castro S; Machado HC; Bahamondes L; Monteiro I
    Contraception; 2022 Jan; 105():75-79. PubMed ID: 34496300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system.
    Gemzell-Danielsson K; Inki P; Heikinheimo O
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1177-88. PubMed ID: 21854367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes of Israeli gynecologists towards the levonorgestrel-releasing intrauterine system: a questionnaire survey.
    Ben-Haroush A; Oron G; Yogev Y; Yeshaya A; Kaplan B
    Eur J Contracept Reprod Health Care; 2004 Mar; 9(1):29-33. PubMed ID: 15352692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.